MedEffect Canada
Features
For industry information about COVID-19, visit our COVID-19 health product industry section.
MedEffect Canada provides consumers, patients, and health professionals with easy access to:
- Report an adverse reaction or side effect;
- Obtain new safety information on drugs and other health products; and
- Learn and better understand the importance of reporting side effects.
Latest Advisories and Recalls
Search for advisories and recalls in the Recalls and Safety Alerts Database
What's New
- Diamorphine being added to list of opioids (Part B): Notice of amendment [2022-01-14]
- Esophageal Stents - Summary Safety Review [2022-01-13]
- Xeljanz/Xeljanz XR (tofacitinib) - Summary Safety Review [2022-01-12]
- Monthly Update to the Canada Vigilance adverse reaction online database [2022-01-07]
- Monthly Update to the List of New Safety and Effectiveness Reviews [2022-01-05]
Related Resources
Report a problem or mistake on this page
- Date modified: